Serological hepatitis markers integrated into clinical care: towards clinical response assessment and individualized treatment decisions.
Reduce microvascular injury in patients with myocardial infarction by off-target properties of the medicine ticagrelor.
Pre-emptive, OCT guided stenting of non-obstructive vulnerable coronary lesions in patients after myocardial infarction.
Experimental models and biomarkers for functional decline to allow early diagnosis and efficient interventions.
Therapy for autosomal dominant Polycystic Kidney Disease.
To understand the genetic basis of ALS, Project MinE aims to sequence 22,500 DNA profiles
The FAIRdICT project has shown that (Health) research data can be shared and analyzed in a secure way using the technology of the Internet of FAIR Data and Services.
Hubrecht Institute and miRagen Therapeutics work together to investigate ways to better deliver new medicines to the heart.
Development of a microneedle-based delivery system to inject vaccines pain- and stress-free.
“Sticky” peptides will prevent that by 2050 antimicrobial resistance will be responsible for about 10 million deaths annually.